NRX Pharmaceuticals Q1 2026 Earnings Wider Loss Despite No Revenue Stock Advances SVRA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Pipeline Development Local Bounti Q1 2026 Earnings EPS Beats Estimate Stock Declines on Limited Disclosure BriaCell Therapeutics Q1 2026 Earnings NarrowerthanExpected EPS Loss Despite No Revenue Algorhythm Holdings Inc RIME Q1 2026 Earnings Beats EPS Estimates Despite No Reported Revenue INOD Q1 2026 Earnings EPS Smashes Estimates with 44688 Surprise